No Data
Australian Stocks With U.S. Exposure Could Be a 'Trump Trade' Bet -- Market Talk
Investors looking to bet on so-called "Trump trade" could look to overweight Australian stocks with high U.S. exposure, say Macquarie analysts in a note.
UBS Adjusts ResMed Price Target to $210 From $195, Maintains Neutral Rating
ResMed (RMD) has an average outperform rating and a price target range of $21.64 to $264, according to analysts polled by Capital IQ.Price: 205.06, Change: +1.18, Percent Change: +0.58
Express News | Resmed Inc : UBS Raises Target Price to $210 From $195
Do Weight Loss Drugs Pose a Threat to ResMed Shares?
ResMed Inc (ASX: RMD) shares have been under the spotlight recently after sliding from their previous highs of $33.10 apiece.
VARON Enters CPAP and BiPAP Machine Market With Feature-Rich "Sunny Grand" Series
SEATTLE, July 18, 2024 /PRNewswire/ -- VARON, a leading provider of oxygen concentrator solutions, is thrilled to announce the launch of its new line of CPAP (continuous positive airway pressure)
Returns On Capital Are A Standout For ResMed (NYSE:RMD)
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. In a perfect world, we'd like to see a company investing more
CyborgJack : tell us something we don't know! I can ask chatgpt for what you just told me lol.
Kevin TraversOP CyborgJack: do it then
Paul Anthony Chin :
Kevin TraversOP Paul Anthony Chin: WOAH HOLY CRUD
Rusty Shackleford 1 Kevin TraversOP: You didn't notice it says practice
View more comments...